Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, United States
Tanya R Cully
Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, United States
Rituraj Pal
Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, United States
Irina V Larina
Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, United States
Kirill V Larin
Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, United States; Department of Biomedical Engineering, University of Houston, Houston, United States; Interdisciplinary Laboratory of Biophotonics, Tomsk State University, Tomsk, Russia
Skeletal muscle from mdx mice is characterized by increased Nox2 ROS, altered microtubule network, increased muscle stiffness, and decreased muscle/respiratory function. While microtubule de-tyrosination has been suggested to increase stiffness and Nox2 ROS production in isolated single myofibers, its role in altering tissue stiffness and muscle function has not been established. Because Nox2 ROS production is upregulated prior to microtubule network alterations and ROS affect microtubule formation, we investigated the role of Nox2 ROS in diaphragm tissue microtubule organization, stiffness and muscle/respiratory function. Eliminating Nox2 ROS prevents microtubule disorganization and reduces fibrosis and muscle stiffness in mdx diaphragm. Fibrosis accounts for the majority of variance in diaphragm stiffness and decreased function, implicating altered extracellular matrix and not microtubule de-tyrosination as a modulator of diaphragm tissue function. Ultimately, inhibiting Nox2 ROS production increased force and respiratory function in dystrophic diaphragm, establishing Nox2 as a potential therapeutic target in Duchenne muscular dystrophy.